This CE webinar provides healthcare professionals with practical strategies for using dietary and herbal support to complement GLP-1 agonist medications in patients. The session explores how targeted food choices, nutritional supplements, and specific herbal therapies can support the body during therapy. The course will also cover guidelines for supporting patients who express interest in tapering off GLP-1 agonists through dietary and lifestyle adjustments. Evidence-based recommendations and case studies will help clinicians apply these strategies in clinical practice to optimize outcomes for patients on or transitioning from GLP-1 agonist therapy.*
Herbs discussed include andrographis, gardinia, ginger, berberine, curcumin, and cinnamon.
This webinar is for healthcare professionals and students only.
CE Information - This webinar is pending approval for the following:
• 1.0 credit of Naturopathic Continuing Education by The American Association of Naturopathic Physicians for NDs.
• 1.0 credit of Continuing Professional Education by NCCAOM for Licensed Acupuncturists.
• 1.0 credit of Continuing Professional Education by the PACE program of the Federation of Chiropractic Licensing Boards for DCs.
• 1.0 credit of Continuing Professional Education by the AND for CNSs.
• 1.0 credit of Continuing Professional Education by the CDR for RD/DTRs.
• To receive CE credit, you must attend the live event and register using applicable credentials.
• Eligible for ND, RD, DTR, CNS, and LAc in the US only. PACE approval includes some Canadian territories.
• After attending the live event, you will receive your CE certificate via email within 2-3 weeks.
•
SPECIAL NOTE for NDs in OREGON: The Oregon Board of Naturopathic Medicine (OBNM) has changed their CE approval process and will not review nor pre-approve events. Oregon CE will be submit for approval post-webinar.
•
SPECIAL NOTE for DCs: PACE is not approved in all states. Please confirm eligibility with your jurisdiction. A list of approved states may be found here:
https://pacex.fclb.org/pages/BoardRequirements.php.
*These statements have not been evaluated by the Food and Drug Administration. This webinar and/or products is not intended to diagnose, treat, cure, or prevent any disease.